Quick Facts
HIV-infected people exposed to tuberculosis are 30 to 50 times more likely to develop active TB.Therapeutics
INFECTIOUS DISEASE TARGET | PRODUCT CANDIDATE | R&D PHASE |
---|---|---|
Tuberculosis | SQ109 | Phase 2 |
Tuberculosis | Sutezolid | Phase 2 |
Tuberculosis | SQ609 | Preclinical |
H. pylori Infections / Gastric Disease | SQ109 | Phase 2 |
Gram+ bacterial infections | Sutezolid | Phase 1 complete |
C. difficile Infection | SQ641 | Preclinical |
Crohn’s Disease | SQ641 |
Research |